Form 4 · Filed Feb 4, 2026, 12:00 PM UTC
ARQT/Arcutis Biotherapeutics, Inc.
Matsuda Masaru — See Remarks
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | S | sell | 7,983 | $25 | $203,554 | 142,658 |
| Feb 2, 2026 | S | sell | 8,562 | $25 | $213,793 | 134,096 |
| Feb 2, 2026 | S | sell | 19,379 | $25 | $489,126 | 114,717 |
| Feb 2, 2026 | S | sell | 4,714 | $26 | $120,820 | 110,003 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-005582